ENTITY

SanBio Co Ltd (4592 JP)

30

Analysis

Health Care • Japan

Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.

more

Refresh

Exchange Announcement • 16 Dec 2024 14:30

Announcement On Acquisition And Cancellation Of Stock Options (Share Acquisition Rights)

Exchange Announcement • 16 Dec 2024 14:30

Consolidated Financial Results For The Nine Months Ended October 31, 2024 [Japanese Gaap]

Exchange Announcement • 16 Dec 2024 14:30

Notice Concerning Recording Of Non-Operating Income, Extraordinary Gains, And Deferred Income Taxes

Exchange Announcement • 06 Dec 2024 14:30

The Yield Results Of The Second Commercial Production Run For Akuugo (R)

Exchange Announcement • 15 Nov 2024 14:30

The Results Of The First Commercial Production Run Of Akuugo [R]

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x